European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Dermatological drug tenders in Portugal — market report, March 2025

Dermatological drug tenders in Portugal in March 2025: 291 tenders published (+782% month on month, -5% year on year), and 295 contracts awarded (+260% month on month, +10% year on year), worth €262,020 (awarded value). Buyers with the most tenders: Unidade Local de Saúde da Guarda, E.P.E (33), Unidade Local de Saúde do Alto Ave, E. P. E. (31) and Unidade Local de Saúde da Região de Aveiro, E. P. E. (19); most contracts won: Generis – Farmaceutica, S.A. (21), Overpharma - Produtos Medicos e Farm. (18) and Labesfal-Lab. Almiro, Sa. (17). On average 11.2 bids per contract; 17% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
291
Contracts awarded
295
Contract value awarded
€262,020
Bids per contract
11.2
Tenders published per month
0100200300400Mar 24: 307Mar 24: 307Mar 24Apr 24: 105Apr 24: 105Apr 24May 24: 32May 24: 32May 24Jun 24: 18Jun 24: 18Jun 24Jul 24: —Jul 24Aug 24: 36Aug 24: 36Aug 24Sep 24: 78Sep 24: 78Sep 24Oct 24: 11Oct 24: 11Oct 24Nov 24: 40Nov 24: 40Nov 24Dec 24: 47Dec 24: 47Dec 24Jan 25: 61Jan 25: 61Jan 25Feb 25: 33Feb 25: 33Feb 25Mar 25: 291Mar 25: 291291Mar 25
Contracts awarded per month
0100200300Mar 24: 268Mar 24: 268Mar 24Apr 24: 88Apr 24: 88Apr 24May 24: 31May 24: 31May 24Jun 24: 17Jun 24: 17Jun 24Jul 24: —Jul 24Aug 24: 57Aug 24: 57Aug 24Sep 24: 45Sep 24: 45Sep 24Oct 24: 20Oct 24: 20Oct 24Nov 24: 31Nov 24: 31Nov 24Dec 24: 67Dec 24: 67Dec 24Jan 25: 44Jan 25: 44Jan 25Feb 25: 82Feb 25: 82Feb 25Mar 25: 295Mar 25: 295295Mar 25

The highlighted bar is March 2025. Hover a bar for its figure; the table below has every value.

FigureMarch 2025February 2025ChangeMarch 2024Change
Tenders published29133+782%307-5%
Estimated value—€357,113———
Buyers184+350%27-33%
Contracts awarded29582+260%268+10%
Contract value (awarded)€262,020————
Winners3329+14%32+3%
Bids per contract11.220.0—16.6—
Single-bid contracts17%0%—0%—

Buyers with the most tenders

Companies with the most contracts

Procedures

  • not stated 291

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Dermatological and musculoskeletal drugs

Questions and answers

How many dermatological drug tenders were published in Portugal in March 2025?
291 (by 18 buyers); for comparison, February 2025: 33, March 2024: 307.
Who won the most dermatological drug tenders in Portugal in March 2025?
By number of contracts: Generis – Farmaceutica, S.A. (21), Overpharma - Produtos Medicos e Farm. (18), Labesfal-Lab. Almiro, Sa. (17), Logista Pharma (16) and Fresenius Kabi Pharma Portugal (16); 33 companies won contracts in all.
Which buyers published the most dermatological drug tenders in March 2025?
Unidade Local de Saúde da Guarda, E.P.E (33), Unidade Local de Saúde do Alto Ave, E. P. E. (31), Unidade Local de Saúde da Região de Aveiro, E. P. E. (19), Unidade Local de Saúde Tâmega e Sousa, E.P.E. (18) and Unidade Local de Saúde de Viseu Dão-Lafões, E. P. E. (18).
How competitive were dermatological drug tenders in Portugal in March 2025?
On average 11.2 bids per contract (12 contracts with a known number of bids); 17% of contracts had a single bid.
What were the contracts worth in March 2025?
€262,020 (awarded value, 295 contracts); median about €4,300.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.